Ensign Peak Advisors, Inc Global Blood Therapeutics, Inc. Transaction History

Ensign Peak Advisors, Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$32.4 - $68.18 $2.44 Million - $5.14 Million	75,416 Added 81.3%	168,180 $11.5 Million
Q2 2022 Aug 12, 2022	BUY	$22.3 - $37.39 $1.66 Million - $2.79 Million	74,654 Added 412.23%	92,764 $2.96 Million
Q1 2022 May 16, 2022	SELL	$25.68 - $35.59 $1.43 Million - $1.98 Million	-55,542 Reduced 75.41%	18,110 $627,000
Q4 2021 Feb 11, 2022	BUY	$24.9 - $40.26 $1.83 Million - $2.96 Million	73,552 Added 73552.0%	73,652 $2.16 Million
Q3 2021 Nov 12, 2021	SELL	$25.48 - $37.34 $1.6 Million - $2.34 Million	-62,689 Reduced 99.84%	100 $3,000
Q2 2021 Aug 13, 2021	BUY	$32.46 - $43.42 $1.04 Million - $1.39 Million	32,100 Added 104.6%	62,789 $2.2 Million
Q1 2021 May 12, 2021	SELL	$38.94 - $50.85 $4.23 Million - $5.52 Million	-108,569 Reduced 77.96%	30,689 $1.25 Million
Q4 2020 Feb 12, 2021	BUY	$37.65 - $63.77 $770,243 - $1.3 Million	20,458 Added 17.22%	139,258 $6.03 Million
Q3 2020 Nov 12, 2020	BUY	$52.76 - $74.49 $1.54 Million - $2.17 Million	29,180 Added 32.56%	118,800 $6.55 Million
Q2 2020 Aug 12, 2020	BUY	$48.73 - $81.82 $1.2 Million - $2.01 Million	24,570 Added 37.77%	89,620 $5.66 Million
Q1 2020 May 11, 2020	BUY	$41.72 - $87.2 $1.51 Million - $3.16 Million	36,288 Added 126.17%	65,050 $3.32 Million
Q4 2019 Feb 14, 2020	BUY	$45.7 - $81.86 $1.31 Million - $2.35 Million	28,762 New	28,762 $2.29 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ensign Peak Advisors, Inc with notifications on news.